Business Wire

NEUSTAR

1.12.2021 15:48:03 CET | Business Wire | Press release

Share
Neustar Security Services Spins Out with Focused Investment to Foster Accelerated Growth

Neustar Security Services , LLC (“Neustar Security Services”), a leading global provider of cloud-oriented security services that enable global business to thrive online, has become the newest portfolio company of Golden Gate Capital and GIC following the completed sale of Neustar Inc.’s (“Neustar”) Marketing, Risk and Communications solutions businesses to TransUnion.

The spin out marks Neustar Security Services’ entry into its next phase of growth with the focused backing of its investors and strong continuity of leadership. Brian McCann, who has served as President of Neustar’s Security business since 2019, has been appointed CEO of Neustar Security Services and will lead the company’s more than 250 employees. Neustar President and CEO, Charlie Gottdiener, will serve as a Director on the Neustar Security Services Board of Directors. In addition to McCann, the Company’s senior leadership team will include Anthony Chadd, Senior Vice President and Chief Revenue Officer; Carlos Morales, Senior Vice President, Solutions; Mark Robinson, Senior Vice President, Technology; and James Willett, Senior Vice President, Operations.

The move follows four years of strategic investment that has enabled Neustar Security Services to become a leading cloud-oriented security services provider, resulting in increased resilience against disruptions and cyberattacks. With support from Golden Gate Capital and GIC, Neustar Security Services re-architected its platforms and significantly expanded network capacity and performance for DNS and DDoS services, adding a host of new solutions and features across its Ultra Secure product portfolio and services suite. It also launched seamlessly integrated offerings for cloud WAF and bot management to address application security, and new threat feed data services to increase visibility to threat intelligence platforms. Together, these investments have improved Neustar Security Services’ performance and security for current and future Global 5000 enterprise customers.

“Today is a very exciting day, and the dawn of a new era for Neustar Security Services,” said Mr. McCann. “Through the successful execution of its multi-year transformation strategy, Neustar Security Services has established a highly scalable, fully cloud-delivered platform with capacity to support multiple mission-critical security services with the highest service and performance in the industry. Our core DNS, DDoS and application security services provide the industry’s best combination of performance, availability, and security for any enterprise. The Neustar Security Services team will remain focused on delivering reliability and demonstrating our commitment to always doing more for our customers while developing additional industry-leading services and further expanding our global reach.”

Rishi Chandna, Managing Director at Golden Gate Capital, said, “Sophisticated cyberattacks are constantly evolving, and we are consistently impressed by Neustar Security Services’ ability to help their customers combat the next generation of challenges and threats. Neustar Security Services has an impressive platform, vision and strategy to drive significant value and growth, and we are excited to partner with Brian and his talented team to support the company in this next chapter.”

“Golden Gate Capital and GIC are committed to implementing a targeted investment strategy that will support Neustar Security Services’ ability to continuously develop and enhance its industry-leading technology and services,” said Mr. Gottdiener. “We believe that the company’s intensified focus as a stand-alone entity will enable it to act with greater agility and dynamism as it addresses the massive and growing market need for cloud-based security solutions.”

In addition to offering newly integrated services in the Ultra Secure portfolio, the company will continue to accelerate the expansion of its sales, marketing and service capabilities while looking to capitalise on its recently revamped and relaunched channel offering, the Ultra Secure Partner Program , to better serve its Global 5000 customer base.

Neustar Security Services will continue to support its global base of enterprise customers from its current headquarters in Sterling, Virginia.

About Neustar Security Services

The world’s top brands depend on Neustar Security Services to safeguard their digital infrastructure and online presence. Neustar Security Services offers a suite of cloud-delivered services that are secure, reliable, and available to enable global businesses to thrive online. The company’s Ultra Secure suite of solutions protects organisations’ networks and applications against risks and downtime, ensuring that businesses and their customers enjoy exceptional interactions all day, every day. Delivering the industry’s best performance service, Neustar Security Services’ mission-critical security portfolio provides best-in-class DNS, application and network security including DDoS, WAF and Bot management, and threat feed services to its Global 5000 customers and beyond. For more information, visit https://www.home.neustar/security-solutions .

About Golden Gate Capital

Golden Gate Capital is a San Francisco-based private equity investment firm with over $19 billion in cumulative committed capital. The principals of Golden Gate Capital have a long and successful history of investing across a wide range of industries and transaction types, including going-privates, corporate divestitures, and recapitalisations, as well as debt and public equity investments. Notable software and technology-enabled services investments sponsored by Golden Gate Capital include Infor, BMC Software, LiveVox, Vector Solutions, Ex Libris, 2020 Technologies and Ensemble Health Partners. For more information, visit www.goldengatecap.com .

About GIC

GIC is a leading global investment firm established in 1981 to secure Singapore’s financial future. As the manager of Singapore’s foreign reserves, we take a long-term, disciplined approach to investing and are uniquely positioned across a wide range of asset classes and active strategies globally. These include equities, fixed income, real estate, private equity, venture capital and infrastructure. Our long-term approach, multi-asset capabilities and global connectivity enable us to be an investor of choice. We seek to add meaningful value to our investments. Headquartered in Singapore, we have a global talent force of over 1,800 people in 10 key financial cities and have investments in over 40 countries.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye